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A. ABSTRACT
Osteoporosis is a skeletal disease that currently affects 10 million Americans, and is
characterized by low bone mass and increased skeletal fragility (National Osteoporosis
Foundation, 2011). Estrogen loss, which begins during menopause, is the leading cause of
osteoporosis in women. Recent research has focused on changes in cortical bone microporosity
due to estrogen loss, which is important for bone health; load-induced interstitial fluid flow
within the lacunar-canalicular porosity surrounding osteocytes is thought to play an important
role in bone maintenance, while the vascular porosity provides a pressure relaxation mechanism
for the fluid flow in the lacunar-canalicular porosity. Recent high-resolution micro-CT studies
show that the cortical vascular porosity and average vascular canal diameter increase in the tibia
metaphysis of ovariectomized (OVX) rats (Larriera et al., 2010). The present study investigated
whether osteoclast resorption is responsible for the increased canal diameter, and if changes in
the cortical blood vessel morphology occur due to estrogen loss. Alterations in the vascular
porosity and bone vasculature were assessed using the rat OVX model at one and two weeks
post-OVX, and analyzed histologically using TRAP enzyme and Goldner’s Trichrome staining.
No differences in TRAP activity or vasculature morphology between OVX and sham-operated
animals were found for all measurements one and two weeks post-surgery, signifying that
osteoclast resorption may not be the primary mechanism for the increased canal diameter
demonstrated previously. These results also suggest that cortical blood vessel morphology is
unchanged at these time points. All parameters quantified in this thesis will be analyzed six
weeks post-OVX to see if there are changes at the time point corresponding to the previous
micro-CT analyses. While additional research is needed, this study begins to unveil the ways in
which postmenopausal osteoporosis affects the microporosity in cortical bone.
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B. BACKGROUND AND SIGNIFICANCE
B.1 Introduction
Osteoporosis is the leading bone disease in the United States (National Osteoporosis
Foundation, 2011), and osteoporosis due to estrogen loss severely affects postmenopausal
women. To date, the ways in which variations in the vascular porosity and blood supply
contribute to changes in bone health and communication between cells have not been clearly
explained. This study aims to identify changes occurring in the vascular porosity due to
postmenopausal osteoporosis as assessed through the ovariectomized rat model and histological
techniques.
B.2 Bone Overview
The skeletal system is composed of connective tissue including bone, cartilage,
ligaments, and tendons. Bone is responsible for protection of the internal organs, structural
support, movement, haematopoiesis (blood cell formation through bone marrow), calcium
storage, and endocrine regulation (Jee, 2001). Tendons and ligaments connect bone to muscle
and bone to bone, respectively, linking the body’s structural support and the mechanical force of
movement.
Bone is 65% inorganic (or mineral) material and 35% organic material including cells,
proteins, and water (Downey and Siegel, 2006; Robey and Boskey, 2008). The organic matrix of
bone is composed of 95% type I collagen and 5% non-collagenous proteins (Marks and Odgren,
2002), which are responsible for organizing the cellular matrix, mineral-matrix interactions, and
mineralization (Robey and Boskey, 2008). The organic matrix is deposited by bone forming
cells, and is then infiltrated by the mineral component of bone, hydroxyapatite
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(Ca10(PO4)6(OH)2). Hydroxyapatite strengthens bone, and provides a source of ions and minerals
(Robey and Boskey, 2008).
Cortical (or compact) and cancellous (or
trabecular) are the two types of bone in the adult
skeleton with relative amounts of 80% and 20%,
respectively (Downey and Siegel, 2006). Cortical bone
is the thin outer shell, while cancellous bone is the
inner portion of bone found in the proximal and distal
sites of long bones (Figure 1). While cortical bone
accounts for more mass than cancellous bone, it covers
less total bone surface, and, in humans, is largely

Figure 1. Cortical and cancellous bone. Adapted
from [Downey and Siegel, 2006].

composed of primary and secondary osteons. Osteons
(250-300 µm in diameter) (Robling et al., 2006) are vascular canals surrounded by concentric
circles of lamellar bone, and secondary osteons are a product of bone remodeling (Figure 2).
Osteons make up the inter-network of cortical bone, and are connected by the lacunar-canalicular
porosity (Section B.5).
B.3 Bone Cells
Osteocytes, osteoclasts, osteoblasts, and bone-lining cells are the four types of bone cells
responsible for bone formation, resorption, maintenance, and health. Osteoblasts are boneforming cells derived from mesenchymal cells, and are approximately 15 to 30 µm in diameter
(Jee, 2001). They are cuboidal in shape, and secrete type I collagen and bone matrix proteins in
order to form the organic matrix.
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Osteocytes are derived from osteoblasts that become embedded in the mineralized matrix,
and are responsible for mechanotransduction and bone health. These cells sit in lacunae (10 to 20
µm) (Ardizzoni, 2001; Bonewald, 2008) and have long processes located in canaliculi (100-300
nm diameter) (You et al., 2004; Bonewald, 2006) that branch off the osteocyte lacuna and travel
through the bone matrix (Klein-Nulend et al., 2003) (Figure 2). The canaliculi contain the
osteocyte’s dendritic protrusions that also extend throughout the matrix, and are surrounded by a
pericellular space and fluid (~80 nm wide on each side) (You et al., 2004). The osteocytes’
dendrites connect with other cells via gap junctions (Doty, 1981), and with the periosteum, blood
vessels, and bone marrow (Klein-Nulend et al., 2003; Bonewald, 2006). Interstitial fluid flows
around

the

osteocyte

process,

through the canaliculi, and initiates
osteocyte signaling in bone (Wang
et al., 2007).
Osteoclasts are large cells
(20 to 100 µm) with many nuclei
(Jee,

2001).

These

cells

are

responsible for the remodeling of
bone and bone resorption. The
enzyme

Tartrate-Resistant

Acid

Phosphatase (TRAP) is an enzyme

Figure 2. Part of an osteon with osteocytes and canaliculi embedded in
lamellar bone. Adapted from [Cowin, 1999].

released to by the osteoclast during bone resorption, and is a well-known marker for osteoclast
activity and differentiation (Anderson and Marks, 1989).
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Bone-lining cells, approximately 1 µm thick and up to 12 µm long (Jee, 2001), are
inactive osteoblasts that flatten out and line the quiescent bone surfaces; they can be quickly
converted back to osteoblasts when needed (Robling et al., 2006). In response to anabolic agents
or mechanical stimuli, bone-lining cells can induce bone formation, without being coupled with
bone resorption (Jee, 2001; Robling et al., 2006). This formation, known as formation drifts,
leads to bone modeling and geometric changes in bone shape.
B.4 Bone Turnover
Bone is constantly undergoing remodeling. This remodeling is a result of bone turnover,
or the constant balance between bone formation and resorption. Exercise and weight bearing
activities can increase bone formation, whereas disuse, estrogen deficiency, and zero gravity can
increase bone resorption (Riggs et al., 1998; Jee, 2001; Downey and Siegel, 2006; Robling et al.,
2006).
Bone formation occurs by the laying down of an organic matrix. This organic matrix,
known as the osteoid, is unmineralized bone mostly composed of type I collagen. The osteoid is
then mineralized by infiltration of hydroxyapatite. Bone resorption occurs by osteoclast activity
breaking up the mineral matrix and releasing hydroxyapatite into the bone environment. When
calcium or phosphates are needed for mineral homeostasis osteoclasts erode the hydroxyapatite
and release essential ions, such as calcium.
Bone turnover replaces damaged, pre-existing bone with new bone, and is a coupling
mechanism between bone formation and
resorption. This coupling mechanism
occurs through the basic multicellular
unit (BMU) (Jilka, 2003) (Figure 3).
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Figure 3. Basic multicellular unit. Adapted from [Parfitt, 2000].

Osteoclasts lead the BMU and tunnel through bone, eroding mineralized matrix as the cell
cluster, known as the cutting cone, advances (Figure 3). The closing cone is composed of
osteoblasts that follow the cutting cone and lay down the osteoid shortly after old bone is
resorbed. There is a lag time between the resorption and formation parts of the BMU, which is
referred to as the resorption cavity. A capillary runs through the center of the BMU providing a
blood supply, which supplies nutrients, oxygen, and cells necessary for bone turnover.
B.5 Bone Porosities
There are three types of porosity found in bone: the lacunar-canalicular porosity
surrounding osteocytes, the vascular porosity, and the collagen-apatite porosity. The collagenapatite porosity (< 10 nm radius) is the space between the mineral component of bone and the
collagen substructure, created when mineral apatite infiltrates and strengthens the initially
constructed collagen matrix (Cowin, 1999; Wang et al., 2004). The role of the collagen-apatite
porosity is unclear; bone fluid is considered to be bound in this matrix, and is not believed to
participate in interstitial fluid flow (Wang et al., 2004).
The lacunar-canalicular porosity (~100 nm diameter) is the site of interstitial fluid flow
around osteocytes (Fritton and Weinbaum, 2009). Fluid flow through the canaliculi and around
the osteocytes regulates cell signaling and solute transport, which are important for overall bone
health, as well as repair, turnover, and bone formation.
The vascular porosity is larger than the lacunarcanalicular porosity, and is approximately 20-40 µm in
diameter (2050 µm2 cross-sectional area in humans)
(Stein, 1999; Fritton and Weinbaum, 2009) (Figure 4).
Within the vascular canals are blood vessels, nerves,
Figure 4. Connections between lacunar-canalicular
porosity and vascular porosity. Adapted from [Fritton
and Weinbaum, 2009].
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and interstitial fluid. Together, the longitudinally and transversely (Volkman’s canals) oriented
vascular canals make up the vascular porosity (Fritton and Weinbaum, 2009). These canals carry
nutrients to and waste away from the lacunar-canalicular porosity (Cowin, 1999) (Figure 4).
Once cellular waste returns to the blood vessels it is transported out of bone through the
periosteum and into the systemic venous circulation.
The lacunar-canalicular and vascular porosities are connected to facilitate bone’s
transport mechanism. Bone acts as a poroelastic material, i.e., a porous solid filled with fluid
(Piekarski and Munro, 1977; Cowin, 1999). Movement-induced loading exerts mechanical forces
on bone, causing fluid pressure to increase within the pores. This increase in pressure creates a
gradient, and causes fluid flow through bone (Cowin, 1995; Knothe Tate, 2003). Shear stress and
the resulting drag forces from this fluid movement are believed to allow osteocytes to sense
changes in their environment, and are the important mechanisms for bone signaling (KleinNulend et al., 2003; Wang et al., 2007). The vascular porosity connects with the lacunarcanalicular porosity, and not only serves as a source for nutrients and cells, but also provides a
pressure relaxation mechanism to help regulate the interstitial fluid flow (Cowin, 1999).
B.6 Bone Mechanotransduction
Bone mechanotransduction is the signaling process that converts mechanical forces to
biochemical and cellular responses to maintain bone structure (Klein-Nulend et al., 2003; Fritton
and Weinbaum, 2009). Since osteocytes are present in high numbers in bone, and have an
interconnected structure with a large surface area, they are thought to be the cells responsible for
detecting strain and translating strain into signaling (Bonewald, 2006). The osteocyte processes
are connected to the canalicular wall via tethering elements and integrin attachments (Wang et
al., 2007) (Figure 5). The most established theory suggests that fluid flow through the
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pericellular space surrounding the osteocyte dendrite creates a drag force, deforming these
tethering elements (Wang et al., 2007) (Figure 5). The combination of the tethering elements and
integrin attachments at the canalicular and cell surfaces results in strain amplification. Since
realistic tissue-level strains from movement-induced mechanical loading are approximately 0.040.3% (Fritton et al., 2000; You et al., 2004), and too small to cause a signaling cascade, strain
amplification is a vital process for mechanotransduction (You et al., 2004). Changes in number
or pattern of the tethering elements due to disease could disrupt fluid flow, altering shear stress

Figure 5. (Left) EM images of an osteocyte process, demonstrating the tethering elements and canalicular protrusions that
connected the process to the canalicular wall. (Right) Model of osteocyte process, canaliculus, and associated integrin
attachments. Adapted from [Wang et al., 2007].

and drag forces (Knothe Tate, 2003).
Osteocyte signaling for coordination of bone activity is a vital aspect of
mechanotransduction. Signaling is thought to occur via integrin receptors on the osteocyte
membrane, which secrete signaling molecules such as nitric oxide (NO), specifically eNOS
(endothelial nitric oxide synthase) and prostaglandins (Klein-Nulend et al., 2003). NO is
expressed by osteocytes, osteoblasts, and endothelial cells, due to shear stress, which is caused
by mechanical loading and fluid flow (Bonewald, 2006). Nitric oxide inhibits osteoclast
function, but stimulates osteoblast differentiation and activity (Kasten et al., 1994; Hikiji et al.,
1997; Bonewald, 2006). NO also protects endothelial cells against apoptosis, and may have a
similar effect on osteocytes (Tan et al., 2008). Additionally, estrogen has been shown to increase
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nitric oxide production and bioavailability in the endothelium (Duckles and Miller, 2010) and in
bone (Armour and Ralston, 1998; van’t Hof and Ralston, 2001). NO is an important mediator of
bone, and changes in expression of nitric oxide could significantly alter the balance between
formation and resorption.
Prostaglandins are also important signaling molecules for mechanotransduction. As with
nitric oxide, prostaglandins, specifically PGE and PGI, inhibit osteoclast activity, but promote
osteoblast activity (Bergmann et al., 2010). Osteocytes produce prostaglandins in response to
shear stress. Because prostaglandins prevent osteocyte apoptosis, decreases in prostaglandin
levels cause cell death, sequentially causing osteoclast bone resorption (Bonewald, 2006).
B.7 Long Bones
A typical long bone contains three main regions: the
epiphysis, metaphysis, and diaphysis (Figure 6). The epiphysis,
the widest part of long bones, is covered by articular cartilage,
and bears most of the mechanical loading, which is transmitted
down to the diaphysis. The metaphysis contains the growth
plate, or epiphyseal plate, and connects the epiphysis and
diaphysis. The epiphyseal plate is hyaline cartilage, present in
growing animals, and the site of longitudinal growth; this plate
calcifies into cancellous bone during puberty, after which
longitudinal growth stops. The diaphysis is the longest part of a
long bone, and contains cortical bone and the medullary cavity

Figure 6. Structure of a long bone.
Adapted from [Jee, 2001].

(Figure 6). The periosteum is the highly vascular lining that encases the outer surface of bone.
The medullary cavity contains bone marrow, and is surrounded by a thin lining known as the
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endosteum. There are two types of bone marrow, red and yellow marrow, which are a part of the
bone vasculature. Red marrow is responsible for formation of platelets and red and white blood
cells, and yellow marrow is composed of fat cells. The function of yellow marrow is not well
understood (Rosen et al., 2009).
B.8 Blood Supply in a Long Bone
Bone vasculature is extremely important in maintaining the everyday functions of long
bones; it is also important during trauma and disease. Bone receives a large portion of the body’s
total cardiac output, about 17% (Brookes and Revell, 1998), and this high vascularity of bone
allows for turnover and repair. Bone vasculature is also an important regulator of vasoactive
factors and hormones in bone, which are crucial for regulation of the skeleton (McCarthy, 2006).
Since blood flow is necessary for bone formation and function (Parfitt, 2000), bone vasculature
is important to consider when studying bone.
The blood supply to human bone is divided into afferent vessels, which lead into the
microvascular network, and then into the efferent vessels. The afferent vessels are composed of
nutrient arteries that extend from a nearby systemic artery (Winet, 2001). This systemic artery
bifurcates, and forms an elaborate blood vessel network surrounding the bone (Brookes and
Revell, 1998). The nutrient arteries arise from this network, and penetrate the epiphysis,
metaphysis, and diaphysis of long bones (Laroche, 2002) (Figure 7). Generally, the epiphysis,
metaphysis, and diaphysis have their own nutrient arteries that distribute blood to each area.
These large arteries penetrate the bone, and continue through the cortex into the bone marrow
(Winet, 2001; Laroche, 2002) (Figure 7). The diaphyseal nutrient artery helps to supply the
growing metaphysis with blood, while the mature metaphysis is solely supplied by the
metaphyseal nutrient artery (Brooks and Revell, 1998; Pazzaglia et al., 2008).
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Once inside the medullary canal of long bones
the nutrient arteries branch, and distribute blood to the
bone marrow and cortical and cancellous bone. The
medullary arterioles result from the bifurcating
nutrient arteries, and are responsible for controlling
blood flow rate through contraction and relaxation of
precapillary sphincters and smooth muscle within the
vessel wall (Laroche, 2002). These arterioles lead into
a bone marrow sinusoidal network, as well as the
capillaries found in cortical bone (Laroche, 2002). The
Figure 7. Arterial blood supply in long bones.
Adapted from [Laroche, 2002].

marrow sinusoids and cortical capillaries connect with

each other at the interface between cortical bone and the medullary cavity (Brooks and Revell,
1998).
The venous circulation in bone is similar to the arterial circulation. Collecting sinuses and
nutrient veins exist not only in the marrow cavity, but also in the periosteum. Veins in the
medullary cavity collect venous blood from the bone marrow sinusoids, whereas veins in the
periosteum and surrounding musculature collect blood from the cortical capillaries (Laroche,
2002). There are many more veins than nutrient arteries in bone, allowing for proper drainage of
blood and interstitial fluid (Brookes and Revell, 1998).
The microvasculature within the cortex supplies cortical bone, and is mainly composed
of capillaries. In human long bones, the blood vessels within the vascular pores run
longitudinally, which results from orientation with the major loading direction, and transversely
(Volkmann’s Canals) (Winet, 2001). There are one to four vessels within each canal (Winet,
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2001), but usually one in the mature skeleton (Brooks and Revell, 1998). An artery and vein can
coexist in the largest canals, but most canals contain capillaries (Laroche, 2002). These
capillaries do not contain smooth muscle, and are approximately 10-20 µm in diameter
(Pazzaglia et al., 2008). The endothelial cell lining is approximately 0.1-0.5 µm thick (Winet,
2001). Angiogenesis (defined as blood vessel formation from pre-existing vessels) can occur at
different points along the length of the vessel, and the diameter can change as well. Thus, vessel
morphology and diameter are largely dependent on cross-sectional sampling.
Blood flow (perfusion) in long bones is centrifugal in young humans and small laboratory
animals, and flows from the medullary cavity towards the periosteum. In general, blood flows
from the systemic arterial circulation through the bone marrow and cortical bone, and back to the
systemic venous circulation (McCarthy, 2006). This centrifugal flow is maintained through a
pressure gradient between the medullary cavity and the periosteum; the blood vessel medullary
cavity pressure is approximately 45-60 mmHg in humans (equal to arterial blood pressure)
(Brooks and Revell, 1998; Cowin, 1999), and the blood vessel periosteal pressure is about 12-15
mmHg (Brooks and Revell, 1998). With aging, it is suggested that blood flow changes from
centrifugal to centripetal; cortical blood flow is then supplied from the periosteal side and moves
toward the medullary cavity (Bridgeman and Brookes, 1996). The reversal of cortical blood flow
in aging long bones is due to medullary ischemia and reduced marrow pressure (Bridgeman and
Brookes, 1996). Blood flow rate in humans is normally about 5 mL/min/100g in cortical bone,
and 20 mL/min/100g in cancellous bone (Laroche, 2002; McCarthy, 2006), which significantly
decreases with aging (Brookes and Revell, 1998).
Bone commonly adapts its shape and size to accommodate different physiological
conditions; the vascular system in bone is no exception. Blood vessels have been shown to
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change morphology during alterations in lifestyle. Exercise, for example, increases the
vasculature (capillary density) in bone in the aging rat (Viboolborakul et al., 2009). Increased
vascularization is also important for fracture repair. Blood clotting and neovascularization are the
first steps in fracture repair, and angiogenesis always accompanies bone formation. Lu et al.
(2008) demonstrated that aging decreases vascularization during fracture healing, and slows the
recovery time in adult male mice. Additionally, Mekraldi et al. (2003) demonstrated that blood
vessel morphology changes in the diseased state. Blood vessel number and area decreased in the
secondary spongiosa of the rat tibia after ovariectomy, and VEGF and nitric oxide expression
was reduced. More research is needed to determine how estrogen reduction affects the bone
vasculature.
The relationship between estrogen and the bone vasculature is important to fully
understand how menopause initiates osteoporosis. While estrogen is known to affect afferent
vessels, the ways in which estrogen influences capillary-sized vessels in cortical bone is less
understood. Bone arterioles have estrogen receptors, specifically ER-α and ER-β, and thus have
the capacity to respond to estrogen (Braidman et al., 2001; Soukhova-O’Hare et al., 2005).
Endogenous estrogens are thought to act as vasodilators on bone arterioles; therefore, decreases
in this hormone due to estrogen loss would stimulate vasoconstriction, and decrease the size of
the blood vessels (Soukhova-O’Hare et al., 2005). Additionally, ER-β receptors have been found
on osteoblasts and osteocytes, and in osteoclast nuclei and capillaries in bone (Braidman et al.,
2001). This suggests that estrogen could have an effect on capillary-sized vessels as well. Since
capillaries do not have smooth muscle, it is most plausible that any changes in morphology of
bone capillaries are dictated by what occurs in the bone arterioles and larger vessels. The effect
of estrogen on capillaries is, therefore, less about direct vasodilation/vasoconstriction, and is
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most likely related to changes in shear stress and endothelial dysfunction, characterized by
reduced nitric oxide availability and increased oxidative stress (Flammer and Lüschera, 2010). In
the rat OVX model (12-14 weeks old), Soukhova-O’Hare et al. (2005) demonstrated that bone
medullary arterioles express ER-α, ER-β, and endothelial nitric oxide synthase (eNOS)
receptors, and that OVX arterioles have a smaller baseline diameter relative to the control;
however, this study found no difference in eNOS expression or NO-dependent dilator effects on
bone arterioles. Although no change in eNOS expression was observed, these measurements
were from the bone marrow blood vessels, and cortical bone capillaries could respond
differently. Decreases in NO production by endothelial cells in cortical capillaries could decrease
the overall NO levels in cortical bone, thus stimulating osteoclasts, inhibiting osteoblasts, and
affecting osteocyte signaling.
Clearly, connections do exist between the bone vasculature, estrogen levels, and
osteoporosis in postmenopausal women; more in-depth studies need to be performed to more
clearly define the relationship between these factors.
B.9 Bone Vasculature and Blood Vessel Assessment
Limited information exists on the bone vasculature, partially due to the difficulty of
studying vessel morphology and blood flow in bone. Vessel morphology is mainly studied
through three different modalities: histology, immunohistochemistry, and radiographic
techniques. Basic histological staining can be performed on paraffin (for decalcified bone) and
plastic (for calcified or decalcified bone) embedded samples to stain the endothelial cells, blood
cells, and the vessel lumen. Standard, non-specific morphological stains, such as Hematoxylin
and Eosin, color the bone matrix and nuclei of cells. Goldner’s Trichrome is another basic
histological stain that can be used with calcified tissue, which highlights the osteoid (pink),
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mineralized matrix (green), and cells (brown) (Goldner, 1938). Goldner’s Trichrome has been
used to stain for blood vessels in plastic-embedded calcified bone (Laroche et al., 1996).
Immunohistochemistry is used in paraffin-embedded samples for specific staining of
bone blood vessels and identification of cells. Antibodies such as platelet endothelial cell
adhesion molecule (PECAM-1/CD31) (Lu et al., 2008) and vascular endothelial growth factor
(VEGF) (Garcia-Ramirez et al., 2000; Ferrara and Gerber, 2001) are established endothelial cell
markers, and have been used to identify blood vessels in bone. The aforementioned antibodies
can only be used on decalcified paraffin-embedded samples; this scenario is not ideal for taking
measurements because normal bone is mineralized, and any decalcified morphological
information is not an accurate representation of the in vivo condition.
Radiographic techniques have been used to assess three-dimensional bone vasculature.
Micro-computed tomography (micro-CT) has been used in conjunction with vascular perfusion
techniques. The animal’s vascular system is perfused with a compound such as Barium Sulfate
(Jia et al., 2010; Sider et al., 2010) or Microfil (Sider et al., 2010), and the compound completely
fills the bone capillaries. The vascular system can then be visualized with micro-CT imaging by
separating the blood vessels from the mineralized matrix through thresholding, and
decalcification improves visualization of the blood vessels. While valid options exist for
investigation of the vascular porosity and bone vasculature, they are challenging and a
comprehensive assessment has yet to be performed.
B.10 Osteoporosis
Osteoporosis is the leading bone disease in the United States, affecting approximately 10
million Americans (National Osteoporosis Foundation, 2011). Osteopenia, which is low bone
mass, is the precursor to osteoporosis. Osteoporosis is characterized by a deterioration of bone
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mass and altered microarchitecture, which leads to decreased bone quality, increased bone
fragility, and the risk of fracture. Osteoporosis is caused by an imbalance between the two phases
of bone turnover: formation and resorption (Turner et al., 2001). This imbalance leads to more
osteoclast removal of bone than osteoblast formation of new bone, resulting in an overall loss of
bone mass (Thompson et al., 1995). According to the National Osteoporosis Foundation, women
are more susceptible to osteoporosis than men, and postmenopausal women have an increased
risk of developing osteoporosis due to the extreme decline of estrogen production. A loss in bone
mass can also be caused by prolonged bed-rest, cancer, Paget’s disease, bone inflammatory
diseases such as rheumatoid arthritis, diabetes, and hormone disorders including thyroid,
parathyroid, and testosterone issues (Rodan and Martin, 2000; National Osteoporosis
Foundation, 2011). While these conditions can ultimately lead to bone fragility, estrogen
deficiency remains the most common cause of osteoporosis among women, and is suggested as a
primary impetus for changes in bone mass.
Although osteoporosis more commonly affects women, men can also suffer from this
disease.

The

most

common

causes

of

osteoporosis

in

men

include

secondary

hyperparathyroidism, low androgen levels, glucocorticoid medication, excessive smoking and
alcohol use, gastrointestinal disease, and immobilization. Genetic diseases and issues with
estrogen receptors are also responsible for inducing osteoporosis in men (Riggs et al., 1998).
In order to help alleviate the effects of postmenopausal osteoporosis, and restore quality
of life to these patients, the relationship between estrogen and bone integrity needs delineation.
The exact mechanism of how estrogen loss decreases bone mass remains unclear; however,
recently it has been suggested that estrogen regulates osteoclast and osteoblast function. It is
suggested that osteoblast function significantly decreases due to reduced estrogen levels, while
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osteoclast function is enhanced (Kameda et al., 1997; Tobias and Compston, 1999); this
combination quickly alters bone composition.
Osteocyte viability is also challenged by estrogen-deficient osteoporosis. Osteocyte
apoptosis and bone resorption after estrogen withdrawal have been spatially and temporally
linked (Emerton et al., 2009). Cell death was shown to occur directly before bone resorption, and
to be an important step in signaling osteoclast activity in that same area (Emerton et al., 2009). A
decrease in the number of osteocytes and disruptions in the associated connectivity would
significantly alter interstitial fluid flow in this area, thus compromising mechanotransduction and
bone’s ability to repair damage due to estrogen loss (Emerton et al., 2009).
B.11 Animal Models of Osteoporosis
Currently, the ovariectomized (OVX) rat model is the most scientifically accepted animal
model for studying postmenopausal osteoporosis. This model induces osteopenia in female rats
by removing the ovaries and significantly reducing the estrogen supply. The proper control is
sham-operated rats where the animals undergo surgery, but the ovaries remain intact (Kalu,
1991). This control removes any affects the surgery may have on bone changes. The model is not
an osteoporosis model, but an osteopenia model because fracture does not occur, as seen in some
women suffering from postmenopausal osteoporosis. While some studies show that the rat tibia
continues to grow until approximately 26 weeks of age, with a slower rate in the last several
weeks, other studies have demonstrated that beyond 20 weeks of age tibial growth has essentially
stopped, even though the growth plate remains open (Roach et al., 2003; Horton et al., 2008). It
is important to use a mature rat model so that results are not affected by the continual growth of
immature animals throughout the study.
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Ovariectomy in the rat has been shown to significantly affect cancellous bone in the tibia.
Overall, bone mineral density decreases in the proximal tibia, and this site is the first to exhibit
bone changes from ovariectomy when compared to the spine (Wronski et al., 1986; Francisco et
al., 2011) and femur (Francisco et al., 2011); additionally, the proximal tibia is the anatomical
site that experiences the most severe changes in bone microarchitecture (Francisco et al., 2011).
There is a significant increase in cancellous bone turnover and bone resorption, and a decrease in
total cancellous bone in the proximal tibia (Wronski et al., 1986; Kalu, 1991; Thompson et al.,
1995; Brouwers et al., 2009), which has been observed as early as two weeks post-ovariectomy
(Thompson et al., 1995). Larriera et al. (2010) demonstrated that bone volume fraction and
trabecular number significantly decrease
and

trabecular

increases

in

spacing
the

OVX

significantly
rat

tibia

metaphysis (26 weeks old) six weeks
post-OVX when compared to control
(Figure 8); additionally, this study found

Figure 8. Decreased bone volume fraction in 26-week-old Sprague
Dawley rats sacrificed 6 weeks post-OVX. Adapted from [Larriera et
al., 2010].

no significant changes in trabecular
thickness and structural model index.
Other effects of ovariectomy on cancellous bone include changes in osteoclast number
(Wronski et al., 1986), mineral apposition rate, and bone formation rate, which significantly
increase fourteen days post-OVX (Thompson et al., 1995). Similarly, bone volume ratio, bone
surface ratio, trabecular separation, trabecular number, and connectivity density have been
shown to decrease in the tibia metaphysis, as assessed with micro-CT imaging (Thompson et al.,
1995; Boyd et al., 2006; Francisco et al., 2011). Decreases in these measurements were observed
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two weeks following ovariectomy in some studies (Thompson et al., 1995), and within the first
month in others (Boyd et al., 2006), except connectivity density, which significantly changed
two months after estrogen loss (Boyd et al., 2006). At twelve months post-ovariectomy, changes
in these parameters cease, and bone reaches a new steady state (Thompson et al., 1995). It has
been reported that individual trabeculae transform from plate-like to more rod-like after
ovariectomy (Laib et al., 2001; Boyd et al., 2006; Franciso et al., 2011). The effect of OVX on
trabecular thickness is unclear, with some studies reporting an increase (Waarsing et al., 2004;
Boyd et al., 2006), some a decrease (Francisco et al., 2011), and some no change (Thompson et
al., 1995) when compared to sham controls. Increases in trabecular thickness could indicate
cancellous bone remodeling (Waarsing et al., 2004).
While cancellous bone is more sensitive to estrogen loss than cortical bone, changes in
cortical bone do occur. Endocortical remodeling has been shown to take place in the tibia of the
mature ovariectomized rat, although it did not reach statistical significance compared to sham
(Wronski et al., 1986). Bone apposition on the endosteal side of cortical bone has been coupled
with periosteal bone resorption in the OVX rat tibia metaphysis (10 months old) (Waarsing et al.,
2004). Cortical bone mineral density remains unaffected by estrogen loss, but cortical porosity
and cortical thickness has been suggested to increase and decrease, respectively, which can
significantly affect bone strength (Sietsema, 1995; Nishiyama et al., 2009; Larierra et al., 2010).
It has also been suggested that the combination of ovariectomy and aging more significantly
affects cortical bone (Kalu, 1991).
Preliminary changes in bone vasculature have also been documented in the
ovariectomized rat model. The relationship between blood vessel morphology and ovariectomy
has been studied, albeit superficially. In the secondary spongisosa of the tibia metaphysis,
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Mekraldi et al. (2003) demonstrated a decrease in blood vessel number in Wistar rats (12-13
weeks old) sacrificed one and two-weeks post-ovariectomy. Additionally, this group showed that
blood vessel area decreased in the one week post-ovariectomy group, but the decline in area did
not reach statistical significance in the two weeks post-ovariectomy group (Mekraldi et al.,
2003). VEGF and nitric oxide mRNA expression also decreased one week post OVX. In this
study, all changes in the vasculature due to estrogen were prevented by 17β-estradiol
administration.
Recently, estrogen-deficient osteoporosis has been linked to decreases in bone perfusion,
which have also been characterized in the rat OVX model. Induced osteoporosis increases bone
marrow fat content, and decreases bone mineral density (BMD) and perfusion in the femurs of
humans and rats (Griffith et al., 2008, 2010). Griffith et al. (2010) also demonstrated that there is,
in fact, an inverse relationship between BMD and bone perfusion and marrow fat content, which
is associated with an increase in fat cell number and endothelial dysfunction in the Sprague
Dawley OVX rat model (6 months old). Similarly, aging and simulated microgravity has been
linked to a decrease in BMD and perfusion in the rat femur (Prisby et al., 2007; Colleran et al.,
2000). Aging was also connected to a decrease in endothelial dependent vasodilation (Prisby et
al., 2007).
Although the rat OVX model has been accepted, the rat skeleton does not undergo bone
remodeling the same way as human bone. Disadvantages of the rat OVX model include different
biochemical and cellular pathways than humans, minimal intra-cortical bone remodeling, and a
small bone size, which limits the amount of samples that can be obtained (Kalu, 1991; Turner et
al., 2001). While rats do not have Haversian systems, cortical remodeling does occur and is more
closely correlated with age than disease (Kalu, 1991). Additionally, the Sprague Dawley OVX
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model is useful to mimic human osteoporosis because the female rats grow more slowly than the
male rats and have an overall smaller peak bone mass, as seen in humans (Turner et al., 2001).
Other osteoporosis models include the mouse, canine, ovine, and primate models. While animals
cannot exactly model the human situation, they are important tools to better understand diseases,
and to predict human outcomes of the same disorder.
B.12 Significance of Project
Understanding the progression of estrogen-deficient osteoporosis is necessary in order to
reduce the risk of fracture, sickness, and death among postmenopausal women suffering from
bone loss and fragility. A vital step to better comprehending this disease is determining changes
that occur within the microporosity in cortical bone due to estrogen loss. While there fails to be
an explicit, well-known relationship between the vascular porosity, mechanotransduction, bone
vasculature, estrogen, and osteoporosis, it is clear that connections do exist. As shown by this
review of the literature, estrogen loss not only directly influences bone cell activity, but can also
affect the cortical vascular porosity. This study investigates the previously observed increase in
the vascular canal diameter in the rat OVX model (Larriera et al., 2010), and potential changes in
the bone vasculature. The combination of changes in these systems may alter interstitial fluid
flow and compromise mechanotransduction. Disruptions in fluid flow means altered solute
transport and shear stresses in the canaliculi, which could potentially lead to insufficient
stimulation of osteocytes and the disruption of regular bone function. The objective of this study
is to analyze morphological changes occurring in the vascular porosity and bone vasculature
resulting from estrogen loss.
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C. PROJECT DESCRIPTION
C.1 Preliminary Studies
One focus of our lab is to delineate the porosity changes occurring in the rat OVX model
and correlate these results to postmenopausal osteoporosis. Previous research has focused on the
lacunar-canalicular porosity surrounding osteocytes; however, this study will center on changes
occurring in the vascular porosity. Our lab has shown in 2D and 3D confocal microscopy studies
that the cortical and cancellous lacunar-canalicular porosity increases due to estrogen loss in the
rat tibia metaphysis six weeks after ovariectomy (Ciani et al., 2009; Sharma et al., 2011). The
recent 3D study showed that the number and volume of osteocyte lacunae, and the number of
canaliculi per osteocyte do not change between OVX and Sham groups, but that the canalicular
volume measured via dye penetration increases in ovariectomized rats by 34% (Sharma et al.,
2011a). Additionally, recent electron microscopy studies from our lab have shown differences in
canalicular wall appearances and morphology (Sharma et al., 2011b). Combining these results
with the confocal microscopy studies suggests that the lacunar-canalicular porosity increases are
due to mineralization or permeability changes in the canalicular walls. Thus, our previous work
implies that fluid flow throughout the osteocyte network is altered in the OVX condition, which
can significantly affect osteocyte health and the osteocytes’ ability to orchestrate proper bone
function (Sharma et al., 2010).
The literature suggests that bone mechanotransduction theories that only account for the
lacunar-canalicular porosity are incomplete, and we have begun to delineate the effects of
estrogen deficiency on the vascular porosity. Most recently we have demonstrated, using highresolution micro-CT imaging (1 µm resolution), that the cortical vascular porosity is increased in
the ovariectomized rat tibia metaphysis (4.10 ± 1.00%) compared to the Sham group (2.80 ±
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0.38%), and that the average vascular canal diameter is increased from 12.5 ± 3.0 µm in Sham to
22.0 ± 4.3 µm in OVX.
While our lab has shown that both the lacunar-canalicular and vascular porosities change
with estrogen loss, the specific effects of ovariectomy on the vascular porosity in the mature rat
model needs delineation and is explored in the following sections. Specifically, research
hypotheses and methods to investigate why the vascular porosity increases and further
morphological changes within the canals and blood vessels are outlined.
C.2 Specific Aims:
The proposed research will test the following global hypothesis:
We hypothesize that estrogen deficiency, as experienced by postmenopausal women, alters
the vascular canal and blood vessel morphology in cortical bone.
From this global research hypothesis, the corresponding specific aims are as follows:
Specific Aim 1: To determine if the increased vascular porosity and average canal diameter
previously observed in rat cortical bone after ovariectomy (Larierra et al., 2010) occurs
through osteoclast resorption. We investigated this specific aim using female Sprague Dawley
rats that underwent ovariectomy at 20 weeks-of-age and were sacrificed 1 and 2 weeks postovariectomy. Osteoclast resorption was assessed through changes in osteoclast numbers and
activity, which were determined by Tartrate-Resistant Acid Phosphatase (TRAP) enzymatic
staining. Samples were obtained from the proximal metaphysis and mid-diaphysis of the rat tibia,
with the region of interest (ROI) being cortical bone.
Specific Aim 2: To determine if estrogen deficiency alters blood vessel number and
morphology in the cortical vascular canals. Using the same rat model as in Specific Aim 1,
Goldner’s Trichrome histological stain was used to determine changes in the number and size of
blood vessels within the cortical vascular canals in the proximal tibia metaphysis.
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D. EXPERIMENTAL METHODS
D.1 Animal Model
The ovariectomized rat model of postmenopausal osteoporosis was used to observe
changes in the vascular porosity due to reduced estrogen levels. Twenty-four female Sprague
Dawley rats (20 week old, Harlan Laboratories) were divided into two groups. The OVX group
(n=12) underwent bilateral ovariectomy, and the Sham group (n=12) underwent sham surgery
where the ovaries were exposed and then returned to the abdominal cavity. The animals were
allowed to acclimatize after surgery for one week and were fed ad libitum. The OVX group was
then pair-fed to the average food intake of the Sham group for the rest of the study. Six animals
from both groups were sacrificed by carbon dioxide inhalation at two different time points postsurgery, one and two weeks (OVX, n=6 and Sham, n=6 for both time points). The animal body
weight and uterine horn weight were recorded at sacrifice. The right tibia of each rat was excised
and cleaned of any soft tissue, and the whole bone length was measured. The tibias were then cut
approximately 2 mm below the growth plate and at the diaphyseal mid-point, and fixed in 10%
phosphate-buffered formalin for 48 hours (Figure 9). Permission for this study was granted by
the Institutional Animal Care and Use Committee at the Hospital for Special Surgery.
Growth Plate
2 mm

Tibia mid-diaphysis ROI

Proximal Tibia ROI
a

Tibia metaphysis ROI

Figure 9. Dissection of tibia for optimal fixation and
histological analysis of different regions. Dotted lines indicate
cutting lines. ROI = Region of interest.
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D.2 Vascular Canal Resorption Analysis
To determine osteoclast activity within the cortical vascular canals, the tibia metaphysis
and mid-diaphysis (see tibia metaphysis and mid-diaphysis ROI, Figure 9) were decalcified in
20% ethylenediaminetetraacetic acid (EDTA) for one week, processed using the Tissue-Tek VIP
machine (Miles Scientific), and embedded in paraffin wax. After embedding, longitudinal
sections of the tibia metaphysis and mid-diaphysis were cut (7 µm thick) using the Leica 2030
Biocut microtome and mounted on Superfrost Plus microscope slides (Cardinal Health). TartrateResistant Acid Phosphatase (TRAP) enzyme staining was performed to quantify osteoclast
activity (Appendix K). Briefly, the sections were brought to water using the graded alcohols and
xylene. They were then soaked in 0.2M Tris-HCl buffer (pH 9.4) for one hour, and in 1M
Sodium Acetate buffer (pH 5.0) overnight. The slides were stained for the TRAP enzyme, and
counterstained with 1% Methyl Green.
A Nikon Microphot-FXA microscope (Hospital for Special Surgery, NY, NY) and
Bioquant software (V8.0) (Bioquant Image Analysis Corporation) were used for the analysis
(Appendix K). For each animal, two measurements were taken for the anterior and posterior
regions of the tibia metaphysis and mid-diaphysis: 1) total number of vascular canals with TRAP
activity (20X objective) and 2) if TRAP activity was present, the total number of osteoclasts
within the vascular canal (40X objective). For each measurement using the 20X objective an area
of cortical bone equal to the microscope field of view (508 µm x 380 µm) was chosen closest to
the metaphysis and mid-diaphysis regions of interest (Figure 9). All measurements taken at 40X
pertained to the canals previously viewed in the 20X ROI. Osteoclasts were identified by the
presence of concentrated red dye and multiple nuclei (Figure 10). One section per anatomical site

27

(anterior metaphysis, posterior metaphysis, anterior mid-diaphysis, posterior mid-diaphysis) per
animal was assessed.

Osteoclast

Figure 10. Example of TRAP activity in the vascular
canals for quantification of osteoclast resorption in
paraffin embedded bone.

D.3 Vascular Canal and Blood Vessel Morphology Analysis
To assess changes in vascular canal and blood vessel number and morphology, the
proximal tibia (Figure 9) from each animal was embedded in polymethyl methacrylate (PMMA)
with the protocol adapted from Erben (1997) (Appendix K). After embedding, whole crosssections were cut (7 µm thick) from the tibia metaphysis approximately 2 mm below the growth
plate (see proximal tibia ROI, Figure 9). The sections were stained with Goldner’s Trichrome
(Goldner, 1938) (Appendix K). Goldner’s Trichrome stains the mineralized matrix (green), the
osteoid (pink), and cells (brown), and was chosen because the vascular porosity morphology and
bone turnover were easy to view. Briefly, the sections were deplasticized in xylene-chloroform
(1:1) and brought to distilled water. The slides were immersed in a series of color stains:
Weigert’s Hematoxylin, Ponceau-acid fuschin, Phosphomolybdic acid, and Light Green. After
each stain the slides were rinsed in either water or 0.5% acetic acid. The sections were then
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dehydrated in ascending grades of alcohol, cleared in xylene, and coverslipped with mounting
media Cytoseal 60 (Richard Allen Scientific).
The Nikon Microphot-FXA microscope and Bioquant software were used for the analysis
(Appendix K). Using the 20X objective, the number of cross-sectional vascular canals and blood
vessels within each canal were determined in the anterior and posterior regions of the proximal
tibia metaphysis (2 ROIs per region) and quantified per unit area. Vascular canal and blood
vessel diameter were measured using the 40X objective (Figure 11). The smallest cross-sectional
diameter was measured for both canal and vessel, and the endothelial cell lining was excluded
from the blood vessel dimensions (Figure 11). For both anterior and posterior regions all
measurements were averaged for three different sections per animal.

Vascular Canal Diameter

Blood Vessel Diameter

Figure 11. Measurement of vascular canal and blood vessel
diameter in PMMA-embedded bone.

D.4 Statistical Analysis
All statistical analyses were performed using Prism 5 (Graphpad Software, Inc.).
Statistical differences between OVX and Sham for body weight, uterine horn weight, and tibia
length were determined using unpaired, two-tailed Student’s t-tests. Differences in TRAP
(osteoclast) activity were determined using a two-way ANOVA with the two factors being
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treatment (OVX vs. Sham) and time post-OVX (one week vs. two weeks) for each anatomical
site (anterior metaphysis, posterior metaphysis, anterior mid-diaphysis, posterior mid-diaphysis).
Differences in vascular canal density, number of blood vessels per canal, vascular canal
diameter, and blood vessel diameter were also assessed for each anatomical site (anterior
metaphysis and posterior metaphysis) using a two-way ANOVA with the two factors being
treatment (OVX vs. Sham) and time post-OVX (one week vs. two weeks). Bonferroni post-test
analyses were performed for all two-way ANOVAs. Results were considered significant for p <
0.05.

E. RESULTS
Ovariectomy was confirmed by uterine horn atrophy. The average uterine horn weight for
OVX rats was significantly less than Sham both one and two weeks post-ovariectomy (Table 1).
While one week after ovariectomy there was no change in body weight, two weeks after surgery
the OVX group had increased in weight compared to Sham (9% increase, Table 1). There were
no differences in tibia length at either time points (Table 2).
Osteoclast resorption as assessed through TRAP enzyme activity was minimal, and there
were no significant differences between groups with respect to anatomical site (metaphysis vs.
mid-diaphysis), region (anterior vs. posterior), or time post-surgery (one week vs. two weeks)
(Table 3). There were no differences in the vascular canal density in Sham and OVX groups with
regard to anatomical site or time post-surgery. Additionally, the average number of blood vessels
per canal was approximately 1.0 for both groups and time points in the anterior and posterior
regions (Table 4). There were also no differences in average vascular canal diameter or average
blood vessel diameter with regard to anatomical site or time post-surgery in Sham or OVX
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groups (Table 5); however, the average vascular canal diameter and average blood vessel
diameter in the posterior metaphysis were significantly smaller compared to the anterior
metaphysis for both Sham and OVX animals at one and two weeks post-surgery (Table 5).

Table 1. Uterine horn and body weights for Sham and OVX groups 1 and 2 week(s) postsurgery.
Uterine Horn Weight (grams)
Body Weight (grams)
Time Post-Surgery
Sham
OVX
Sham
OVX
1 Week
0.53 ± 0.10
0.26 ± 0.03*
225.8 ± 4.8
232.8 ± 8.7
2 Weeks
0.59 ± 0.06
0.17 ± 0.03*
239.5 ± 8.3
261.0 ± 6.6*
*p < 0.05 compared to Sham

Table 2. Right tibia length for Sham and OVX groups 1 and 2 week(s) post-surgery.
Right Tibia Length (cm)
Time Post-Surgery
Sham
OVX
1 Week
3.98 ± 0.04
3.98 ± 0.03
2 Weeks
3.98 ± 0.03
3.99 ± 0.02

Table 3. Average number of vascular canals with TRAP activity and average number of
osteoclasts per active canal in Sham and OVX groups 1 and 2 week(s) post-surgery.
Average Number of Vascular
Average Number of
Canals with TRAP Activity
Osteoclasts per Active Canal
Time PostAnatomical Site
Sham
OVX
Sham
OVX
Surgery
Anterior
1 Week
0.0 ± 0.0
0.0 ± 0.0
0.0
0.0
Metaphysis
2 Weeks
0.2 ± 0.4
0.2 ± 0.4
1.0
1.0
Anterior
1 Week
0.0 ± 0.0
0.2 ± 0.4
0.0
4.0
Mid-diaphysis
2 Weeks
0.0 ± 0.0
0.0 ± 0.0
0.0
0.0
Posterior
1 Week
0.2 ± 0.4
0.0 ± 0.0
4.0
0.0
Metaphysis
2 Weeks
0.0 ± 0.0
0.0 ± 0.0
0.0
0.0
Posterior
1 Week
0.0 ± 0.0
0.2 ± 0.4
0.0
1.0
Mid-diaphysis
2 Weeks
0.0 ± 0.0
0.2 ± 0.4
0.0
2.0
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Table 4. Average vascular canal density and number of blood vessels per canal for Sham and
OVX groups 1 and 2 week(s) post-surgery.
Average Vascular Canal
Density (# canals/mm2)
Anatomical
Site
Anterior
Metaphysis
Posterior
Metaphysis

Time PostSurgery
1 Week
2 Weeks
1 Week
2 Weeks

Average Number of Blood
Vessels per Canal

Sham

OVX

Sham

OVX

51.8 ± 18.7
48.4 ± 15.5
52.1 ± 26.6
38.4 ± 20.1

52.5 ± 17.9
45.6 ± 14.9
50.2 ± 21.0
45.8 ± 15.4

1.1 ± 0.4
1.0 ± 0.2
1.0 ± 0.2
1.0 ± 0.2

1.1 ± 0.4
1.0 ± 0.2
1.1 ± 0.3
1.1 ± 0.2

Table 5. Average vascular canal diameter and blood vessel diameter for Sham and OVX groups
1 and 2 week(s) post-surgery.
Average Vascular Canal
Average Blood Vessel
Diameter (µm)
Diameter (µm)
Anatomical
Time PostSham
OVX
Sham
OVX
Site
Surgery
Anterior
1 Week
16.3 ± 6.2
15.2 ± 5.3
10.9 ± 3.9
9.9 ± 3.9
Metaphysis
2 Weeks
14.1 ± 5.1
13.5 ± 4.6
10.2 ± 3.4
10.5 ± 3.9
+
+
+
Posterior
1 Week
12.7 ± 4.7
13.5 ± 5.5
8.4 ± 3.0
8.3 ± 2.9+
Metaphysis
2 Weeks
11.9 ± 4.0+
12.5 ± 4.4+
8.4 ± 2.5+
9.8 ± 3.3+
+p < 0.05 compared to anterior site of same time point and treatment

F. DISCUSSION
The objectives of this study were two-fold: to determine if osteoclast resorption is the
primary mechanism behind the increased cortical vascular porosity and canal diameter
previously observed with micro-CT imaging in the rat OVX model (Larriera et al., 2010), and to
determine the effects of estrogen loss on blood vessel morphology in cortical bone. Both
objectives were assessed one and two weeks after ovariectomy of 20-week-old female Sprague
Dawley rats.
Previous studies determined that the vascular porosity in the cortical tibia metaphysis of
rat bone increases by 32% as assessed 6 weeks after ovariectomy (Larriera et al., 2010). Larriera
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et al. (2010) also reported an increase in vascular canal diameter in this same region in OVX rats.
The present study shows no statistical differences in osteoclast activity in the OVX group
compared to Sham with regard to location, anatomical region, or time. The low level of
osteoclast activity suggests one and two weeks may not be enough time for osteoclast
recruitment and resorption. Studies to quantify changes in osteoclast activity 6 weeks post-OVX
are underway, and this information will provide more concrete conclusions as to if osteoclast
resorption causes the vascular canal changes after estrogen loss reported in Larriera et al. (2010);
however, if insignificant levels of TRAP activity are observed 6 weeks post-OVX, it can be
concluded that osteoclast resorption is not the primary mechanism by which the cortical vascular
porosity increases. In this case other mechanisms need to be considered.
Mineral degradation and bone resorption occur through a pH change in the bone
microenvironment. Osteoclasts, for example, secret hydrogen ions, among other compounds,
which cause an acidic pH change (pH~3.5) and erode bone (Jee, 2001); however, other
mechanisms could potentially create an acidic milieu and initiate bone resorption. Matrix
metalloproteinases (MMPs) are enzymes that can degrade bone through proteolysis (PageMcCaw et al., 2007), and may be important candidates to describe the increased vascular
porosity and canal diameter. Specifically, MMP-2 and 14 are known to cleave type I collagen,
and could contribute to resorption (Page-McCaw et al., 2007). Other mechanisms through which
changes in bone pH could occur include alterations in blood pH or oxygen tension (Arnett,
2010). Griffith et al. (2010) demonstrated decreased perfusion in the rat OVX vertebrae, and this
reduced blood flow could induce hypoxia (low oxygen) in the vascular porosity. Since the bone
vasculature is a part of the vascular porosity, blood acidosis and hypoxia could decrease the pH
inside the vascular canals and increase mineral metabolism.
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For the vascular canal density there were no statistical differences between OVX and
Sham at either time points as assessed through histology. Two weeks is a relatively short time for
bone turnover and alterations in canal density in skeletally mature rats, and it is possible that
changes will be significant 6 weeks post-OVX. Although not statistically different between
Sham and OVX in this study, vascular canal diameter was found to be similar to the Sham values
reported in Larriera et al. (2010). Vascular canal diameter will be quantified in the 6 weeks postOVX time point as well, and is expected to increase in the ovariectomized rats as seen in the
previous micro-CT studies. Throughout the one and two weeks post-surgery animals a circular
osteoid (unmineralized bone) was intermittently present around the circumference of the vascular
canals in equal amounts in Sham and OVX animals (Figure 12). This osteoid thickness will be
quantified in the 6 weeks post-surgery animals to determine any differences between OVX and
Sham groups. No differences in the cortical vascular canal diameter seen in the 6 week time
point animals would contradict the micro-CT data. A potential explanation could be attributed to
micro-CT thresholding, which would have separated the unmineralized osteoid from mineralized
bone and would not have incorporated the osteoid into the canal diameter measurements, thus
reporting a larger diameter than was actually present.

Figure 12. An example of the osteiod (pink) that occasionally surrounds vascular canals in Sham and OVX animals at one and
two weeks post-surgery. Images stained with Goldner’s Trichrome and taken with light microscopy (60X oil immersion lens).

34

Blood vessel diameter remained relatively constant in OVX and Sham groups one and
two weeks after ovariectomy. The average blood vessel diameter was approximately 10.2 µm in
the anterior metaphysis, whereas the posterior metaphysis average blood vessel diameter was
approximately 8.7 µm. While two or three blood vessels were occasionally present in a single
canal, the average blood vessel per canal was approximately 1.0 for both groups and time points.
These results suggest that ovariectomy does not affect blood vessel diameter or number as
observed in other studies that focused on metaphyseal cancellous bone (Mekraldi et al., 2003). It
is well-established that cortical bone is less susceptible to changes following estrogen loss when
compared to cancellous bone, and our findings show that the bone vasculature within cortical
bone is not as affected as in other areas at identical time points (Mekraldi et al., 2003; SoukhovaO’Hare et al., 2005). To continue this work, blood vessel diameter and number will be assessed 6
weeks after ovariectomy to determine if changes occur at a later time. If no differences are
established between OVX and Sham groups at 6 weeks post-surgery it would be plausible to
conclude that the cortical bone vasculature morphology remains unchanged after estrogen loss,
most likely because capillaries have no smooth muscle or auto-regulation. Other changes in the
vasculature could be occurring, which could contribute to alterations in cortical bone
microarchitecture. Decreases in systemic perfusion or decreases in local perfusion due to
blockages would prevent cells, nutrients, and oxygen from reaching cortical bone. This would
significantly impact bone health.

G. CONCLUSIONS
This study investigated the effects of estrogen loss on morphological changes in the
vascular porosity and bone vasculature in rat cortical bone. No significant differences were found
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in vascular canal and blood vessel size or density, or in the amount of osteoclast activity within
the porosity. The results to date indicate that any increases in the vascular porosity as assessed by
micro-CT imaging are not due to osteoclast activity. Additionally, the results suggest that the
cortical bone vasculature is unaffected by estrogen loss; however, only one- and two-week postovariectomy times were investigated. These time points were much earlier than previous
publications that found changes in the vascular porosity. The data is incomplete without looking
at animals six weeks post-ovariectomy (data in progress), and a more complete story will be
available after completion of this last time point. Although preliminary, this work has begun to
incorporate the vascular porosity and bone vasculature into the global picture of postmenopausal
osteoporosis, which will hopefully increase knowledge about this disease.

H. SUMMARY OF FUTURE WORK
All measurements and observations described above will be investigated 6 weeks after
ovariectomy and sham surgeries of 20-week-old female Sprague Dawley Rats (OVX, n=6 and
Sham, n=6). As before, the proximal tibia will be embedded in PMMA for vascular canal and
blood vessel measurements, and the metaphysis and mid-diaphysis will be decalcified in EDTA
and embedded in paraffin bone for assessment of TRAP activity (Figure 9). The following will
be quantified:
Paraffin-Embedded Bone:
All measurements will be taken in the anterior and posterior regions of the tibia metaphysis and
mid-diaphysis.
1. Number of longitudinal vascular canals with TRAP activity in a 508 µm x 380 µm
area of interest
2. Number of osteoclasts in the vascular canals with TRAP activity
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PMMA-Embedded Bone:
All measurements will be taken in the anterior and posterior regions of the tibia metaphysis.
1.
2.
3.
4.
5.
6.

Average vascular canal density
Average number of blood vessels per vascular canal
Average vascular canal diameter
Average blood vessel diameter
Percent of vascular canals surrounded by osteiod
Average thickness of osteoid surrounding the vascular canal (if present)

Additionally, in a separate study the bone vasculature will be further analyzed in the rat OVX
model using the Microfil technique and micro-CT imaging previously described (Section B.9).
Measurements reported in this study will be confirmed using Microfil, and a 3D representation
of the vascular porosity and bone vasculature will be constructed for further analysis.
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K. APPENDIX K – LABORATORY PROTOCOLS
K.1 PMMA Embedding Protocol
1. Dehydration:
- 70% EtOH (2 days)
- 95% EtOH (2 days)
- 100% EtOH (1 day)
- Isopropyl Alcohol (3 days – change once)
- Xylene (3 days – change once)
2. Infiltration:
- Solution 1: 60 mL methylmethacrylate (MMA), 25 mL Butylmethacrylate, 5 mL
metylbenzoate, 1.2 mL polyethylene glycol (3 days)
- Solution 2: 100 mL MMA, 0.4 g benzoyl peroxide (3days)
- Solution 3: 100 mL MMA, 0.8 g benzoyl peroxide (3 days)
Stir each solution for 5 minutes
3. Polymerization:
- Prepare a solid methacrylate base in the embedding vial, polymerize this before
embedding sample
- Solution: 400 µL N,N-dimethyl-p-toluidine added to 100 mL cold (4ºC) MMA and
0.8 g benzoyl peroxide
Stir the solution well and keep on ice
Add the sample and solution to the embedding vial, seal, and polymerize in the freezer for 3 days
K.2 Goldner’s Trichrome Protocol
1. Deplasticize in Xylene-Chloroform (1:1) for 45 minutes
2. 100% EtOH for 10 minutes (2 times)
3. 95% EtOH for 5 minutes
4. 70% EtOH for 5 minutes
5. Distilled water for 5 minutes
6. Weigerts Hematoxylin for 10 minutes
7. Rinse gently in tap water
8. Put the slides in the Ponceau-acid fuchsin staining solution for 12 minutes
9. Rinse in 0.5% Acetic Acid (2 washes)
10. Put slides in the Phosphomolybdic Acid for 9 minutes
11. Rinse in 0.5% Acetic Acid
12. Put slides in the Light Green for 3 minutes
13. Rinse in 0.5% Acetic Acid (2 washes)
14. Dehydrate through ascending grades of alcohols (70%, 95%, 100% - 5 minutes each)
15. Xylene for 5 minutes (3 times)
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16. Coverslip immediately using Cytoseal 60 mounting medium (Richard Allen Scientific)
K.3 TRAP Enzyme Staining Protocol
1. Bring slides to distilled water using Xylene (3 times - 5 minutes each) and graded alcohols
(100%, 95%, 70% - 5 minutes each)
2. 1 hour in 0.2M Tris-HCl buffer (pH 9.4)
3. Overnight in 1M Na Acetate buffer (pH 5.0)
4. TRAP staining as follows:
- Solution A: Dissolve 50 mg Sodium Nitrite in 1.25 mL distilled water.
- Solution B: Take 100 µl of solution A and add 100 µl hexosatised pararosanilin: new
fuchsin, add 35 mL of 1M Na Acetate buffer (pH 5.0) and 35 mg tartaric acid, and
mix well
- Solution C: Dissolve 40 mg of Napthol ASBI phosphate in 2 mL Dimethylformamide
- Add all of Solution B to Solution C
- Filter stain solution and place slides in 37ºC for 20 minutes
5. Counterstain with 1% Methyl Green for 1 minute and rinse in distilled water
6. Do not coverslip with solvent based mounting media - TRAP color will fade
Recipe for 0.2M Tris-HCl (1 Liter):
- 31.52g Trizma Hydrochloride in 700 mL distilled H2O
- pH to 9.4
- Add enough water to make 1 Litre.
- *Note: MW =157.6 for Trizma
Recipe for Sodium Acetate Buffer (500 mL):
- 8.2 g Sodium Acetate in 400mL distilled H2O
- pH to 5.0
- Add enough water to make 500mL
Recipe for Hexosatised Pararosanilin: New Fuchsin
- 1g basic fuchsin in 20 mL distilled H2O with 5 mL concentrated HCl
- Warm gently while mixing
- Store in the dark at 4ºC
- This should produce minute bubbles and discolor 1 min
K.4 Vascular Canal Resorption Analysis Protocol
Objectives:
1. To determine the number of vascular canals within the anterior and posterior regions of the
tibia metaphysis and mid-diaphysis in cortical bone
2. To determine the percentage of these vascular pores that have osteoclast (TRAP) activity
3. To quantify all measurements per unit area
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Analysis Plan:
- 1 longitudinal paraffin-embedded section per animal sectioned at 7 µm
- Measurements taken in the anterior and posterior regions for each section
- 1 ROI per anatomical region
Analysis Protocol:
ROI Selection
1. Open Bioquant V8.00
2. Through the eye-piece, view the longitudinal section in the 1X objective
3. Identify the anterior and posterior regions nearest the proximal end of the section
o Metaphysis sections – anterior site located on the outside portion of each mirror
image of the longitudinally cut bone
o Mid-diaphysis sections – posterior site located on the outside

A
Proximal end

P
4. Focus on the top anterior region for the ROI
5. Switch to the 20X objective

6. Measure the ROI dimensions (___ µm x ___ µm)
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Quantifying Osteoclast activity
1. Select live image and focus image on the computer screen. Then capture image by clicking
live image again
2. Select the following arrays from the “Select Arrays” menu:
o D14 (for counting the number of vascular canals with TRAP activity)
o D15 (for counting the number of osteoclasts if TRAP activity is present)
3. Count the number of vascular pores with TRAP activity at the 20X objective
o Select D14 from the “Select Arrays” menu
o From the “Measure” drop-down menu  Manual Measure
o Click live measure then click measure
o Click on the vascular canals with TRAP staining (osteoclast activity = red staining)
o Switch to the 40X objective
o Select D15 from the “Select Arrays” menu then click measure
o Click on all the osteoclasts that appear for each canal then right click to take
measurement

Vascular pore with no
osteoclast activity
Vascular pore with
osteoclast activity

4.
5.
6.
7.

File  Copy all data
Open Excel
Paste all data and organize
Repeat protocol for posterior region for metaphysis and diaphysis of each animal

K.5 Vascular Canal and Blood Vessel Morphology Analysis Protocol
Objectives:
1. To determine the number of cortical vascular canals and the number of blood vessels within
each canal in the anterior and posterior regions of the tibia metaphysis
2. To measure the diameter of the vascular canals
3. To measure the diameter of the blood vessels
4. To quantify all measurements per unit area
Analysis Plan:
- 3 PMMA-embedded cross-sections per animal sectioned at 7 µm
- Measurements taken in the anterior and posterior regions for each cross-section
- 2 ROIs per anatomical region
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Analysis Protocol:
ROI Selection
1. Open Bioquant V8.00
2. Through the eye-piece view the entire cross-section in the 1X objective

3. Focus on the anterior region
(The anterior region is always the curved point opposite the shortest side)

P

A
4. Focus the viewfinder on the 1st anterior ROI, and then switch to 10X and then to 20X

Counting and
Measuring the Vascular Pores and Blood Vessels for each ROI
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1. Select live image and focus image on the computer screen at 20X. Then capture image by
clicking live image again
2. Select the following arrays from the “Select Arrays” menu:
- A1 (for total tissue area measurement)
- D14 (for counting the vascular canals)
- D15 (for counting the blood vessels per canal)
- I7 (for measuring vascular canal diameter)
- I8 (for measuring blood vessel diameter)
3. Define the ROI by tracing the outline of the cortical bone that appears in the captured image
- From the “Tools” drop-down menu ROI Tools  IROI Cursor  Radius = 1
- Trace all cortical bone with the cursor
- Measure approximate size of ROI with scale bar
4. Create a threshold and measure total tissue area
- Select Mag = 20X from the “Parameters” menu
- Click on Select in the “Threshold” menu
- Click on the ROI until the entire area is red
- From the “Measure” drop-down menu  Automatic Measure
o Make sure additive measure is checked
- Select A1 from the “Select Arrays” menu
- Auto Measure  preview  measure  total tissue area measurement will appear in
the data box (µm2)
- Click on Select in the “Threshold” menu to un-do the threshold
5. Count the vascular pores and blood vessels at 20X objective
- Make sure additive measure is unchecked
- Select D14 from the “Select Arrays” menu
- From the “Measure” drop-down menu  Manual Measure
- Click live measure then click measure
- Click on a vascular canal then right click to take measurement

-

Select D15 from the “Select Arrays” menu then click measure
Click on each blood vessel within that specific canal then right click
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-

Repeat for all other canals within the 20X ROI

6. Measure the diameter of the vascular pores and blood vessels
- Return to live image by clicking live image
- Switch to the 40X objective
- Select Mag = 40X from the “Parameters” menu
- Select I7 from the “Select Arrays” menu
- Click live measure from the “Manual Measure” menu then click measure
- For each vascular canal previously counted at 20X, click on each side of the object’s
smallest diameter then right click to perform measurement
- Select I8 from the “Select Arrays” menu
- Click measure
- For each blood vessel click on each side of the object’s smallest diameter then right
click to perform the measurement
o Do not take into account the endothelial cell lining
- Move on to all additional blood vessels
7. File  Copy all data
8. Open Excel
9. Paste all data and organize for first anterior ROI
10. Repeat protocol steps for the 2nd anterior ROI and copy data to excel sheet
11. Repeat protocol for 1st and 2nd posterior ROI and copy data to excel sheet
12. Repeat protocol for 2nd and 3rd slides for each animal
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